Entity Common Stock, Shares Outstanding of Nurix Therapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nurix Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2020 to Q3 2025.
  • Nurix Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 Sep 2025 was 76.9M shares, a 8.54% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 76.9M +6.05M +8.54% 30 Sep 2025 10-Q 09 Oct 2025
Q2 2025 76.4M +12M +18.7% 30 Jun 2025 10-Q 09 Jul 2025
Q1 2025 76.2M +27.1M +55.1% 01 Apr 2025 10-Q 08 Apr 2025
Q4 2024 75.9M +27M +55.2% 24 Jan 2025 10-K 28 Jan 2025
Q3 2024 70.8M +22.3M +46% 10 Oct 2024 10-Q 11 Oct 2024
Q2 2024 64.4M +16.2M +33.6% 01 Jul 2024 10-Q 11 Jul 2024
Q1 2024 49.2M +1.71M +3.6% 01 Apr 2024 10-Q 10 Apr 2024
Q4 2023 48.9M +1.62M +3.43% 05 Feb 2024 10-K 15 Feb 2024
Q3 2023 48.5M +1.36M +2.88% 02 Oct 2023 10-Q 12 Oct 2023
Q2 2023 48.2M +1.16M +2.46% 30 Jun 2023 10-Q 13 Jul 2023
Q1 2023 47.4M +2.5M +5.55% 31 Mar 2023 10-Q 13 Apr 2023
Q4 2022 47.3M +2.54M +5.67% 31 Jan 2023 10-K 09 Feb 2023
Q3 2022 47.1M +2.54M +5.68% 30 Sep 2022 10-Q 06 Oct 2022
Q2 2022 47M +2.62M +5.89% 30 Jun 2022 10-Q 07 Jul 2022
Q1 2022 45M +603K +1.36% 31 Mar 2022 10-Q 08 Apr 2022
Q4 2021 44.7M +5.83M +15% 21 Jan 2022 10-K 28 Jan 2022
Q3 2021 44.6M +5.76M +14.8% 08 Oct 2021 10-Q 14 Oct 2021
Q2 2021 44.4M 09 Jul 2021 10-Q 13 Jul 2021
Q1 2021 44.3M 09 Apr 2021 10-Q 13 Apr 2021
Q4 2020 38.9M 11 Feb 2021 10-K 16 Feb 2021
Q3 2020 38.9M 07 Oct 2020 10-Q 14 Oct 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.